 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12345 |
- | Olorofim (orotomide) / F2G
New P1 trial: Study of Potential for Interaction of Fluconazole With F901318 (clinicaltrials.gov) - Apr 6, 2016
P1, N=32, Not yet recruiting, Sponsor: F2G Ltd.
- | Olorofim (orotomide) / F2G
New P1 trial: Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe (clinicaltrials.gov) - Feb 12, 2016
P1, N=20, Recruiting, Sponsor: F2G Ltd.
- || Olorofim (orotomide) / F2G
Trial primary completion date: F901318 Multiple Ascending Dose Study (clinicaltrials.gov) - Dec 22, 2015
P1, N=72, Recruiting, Sponsor: F2G Ltd.
Trial primary completion date: Nov 2015 --> Feb 2016
- Olorofim (orotomide) / F2G
Enrollment open, Trial initiation date, Trial primary completion date: Single Ascending Oral Dose Study of F901318 (clinicaltrials.gov) - Dec 22, 2015
P1, N=40, Recruiting, Sponsor: F2G Ltd.
Trial primary completion date: Nov 2015 --> Feb 2016 Not yet recruiting --> Recruiting | Initiation date: May 2015 --> Oct 2015 | Trial primary completion date: Aug 2015 --> Apr 2016
- Olorofim (orotomide) / F2G
New P1 trial: Single Ascending Oral Dose Study of F901318 (clinicaltrials.gov) - Mar 20, 2015
P1, N=40, Not yet recruiting, Sponsor: F2G Ltd.
- Olorofim (orotomide) / F2G
Enrollment open, Trial primary completion date: F901318 Multiple Ascending Dose Study (clinicaltrials.gov) - Feb 20, 2015
P1, N=72, Recruiting, Sponsor: F2G Ltd.
Not yet recruiting --> Recruiting | Initiation date: May 2015 --> Oct 2015 | Trial primary completion date: Aug 2015 --> Apr 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2015 --> Nov 2015
- Olorofim (orotomide) / F2G
New P1 trial: F901318 Multiple Ascending Dose Study (clinicaltrials.gov) - Jan 22, 2015
P1, N=72, Not yet recruiting, Sponsor: F2G Ltd.
- | Olorofim (orotomide) / F2G
Trial completion: F901318 Single Ascending Dose Study in Healthy Male Volunteers (clinicaltrials.gov) - Nov 12, 2014
P1, N=40, Completed, Sponsor: F2G Ltd.
Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2015 --> Nov 2015 Recruiting --> Completed
- Olorofim (orotomide) / F2G
Enrollment open: F901318 Single Ascending Dose Study in Healthy Male Volunteers (clinicaltrials.gov) - Aug 15, 2014
P1, N=40, Recruiting, Sponsor: F2G Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- | Olorofim (orotomide) / F2G
New P1 trial: F901318 Single Ascending Dose Study in Healthy Male Volunteers (clinicaltrials.gov) - May 18, 2014
P1, N=40, Not yet recruiting, Sponsor: F2G Ltd.